Virxsys Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virxsys inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virxsys Inc Today - Breaking & Trending Today

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer


Published: May 10, 2021
 
SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/   Gracell Biotechnologies Inc. (NASDAQ: GRCL) ( Gracell ), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appointment of Dr. Jenny (Yajin) Ni as its Chief Technology Officer (CTO). In her role, Dr. Ni will be responsible for strategically leading CAR-T product development, Chemistry, Manufacturing, and Control (CMC), and supply chain management activities. Dr. Ni will lead the efforts to ensure the smooth technology transfer to Gracell s strategic collaborator, Lonza, for manufacturing of FasTCAR-enabled product candidates in the U.S. ....

Ya Jin , Marvin Tang , William Wei Cao , Exchange Commission , Head Of Process Development , Gracell Biotechnologies Inc , Virxsys Inc , Kyoto University , Gracell Biotechnologies , Chief Technology Officer , Process Development , Allogene Therapeutics , Tech Operations , Molecular Virology , Internal Medicine , Kunming Medical University , Private Securities Litigation Reform Act , மார்வின் டாங் , வில்லியம் வெய் சாவ் , பரிமாற்றம் தரகு , தலை ஆஃப் ப்ரோஸெஸ் வளர்ச்சி , கியோட்டோ பல்கலைக்கழகம் , தலைமை தொழில்நுட்பம் அதிகாரி , ப்ரோஸெஸ் வளர்ச்சி , தொழில்நுட்பம் செயல்பாடுகள் , மூலக்கூறு வைராலஜி ,

Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer


Share this article
Share this article
SUZHOU, China and PALO ALTO, California, May 10, 2021 /PRNewswire/   Gracell Biotechnologies Inc. (NASDAQ: GRCL) ( Gracell ), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appointment of Dr. Jenny (Yajin) Ni as its Chief Technology Officer (CTO). In her role, Dr. Ni will be responsible for strategically leading CAR-T product development, Chemistry, Manufacturing, and Control (CMC), and supply chain management activities. Dr. Ni will lead the efforts to ensure the smooth technology transfer to Gracell s strategic collaborator, Lonza, for manufacturing of FasTCAR-enabled product candidates in the U.S. ....

Ya Jin , Marvin Tang , William Wei Cao , Exchange Commission , Head Of Process Development , Gracell Biotechnologies Inc , Virxsys Inc , Kyoto University , Gracell Biotechnologies , Chief Technology Officer , Process Development , Allogene Therapeutics , Tech Operations , Molecular Virology , Internal Medicine , Kunming Medical University , Private Securities Litigation Reform Act , மார்வின் டாங் , வில்லியம் வெய் சாவ் , பரிமாற்றம் தரகு , தலை ஆஃப் ப்ரோஸெஸ் வளர்ச்சி , கியோட்டோ பல்கலைக்கழகம் , தலைமை தொழில்நுட்பம் அதிகாரி , ப்ரோஸெஸ் வளர்ச்சி , தொழில்நுட்பம் செயல்பாடுகள் , மூலக்கூறு வைராலஜி ,